임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
15건 표시
- 1/2상모집 중· Advanced Solid Tumor CancerEarly-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors
리드: 바이오엔테크
- 1/2상모집 중· Advanced Renal Cell Carcinoma (RCC)A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
리드: BMS · 협력: 바이오엔테크
- 1/2상모집 중· Hepatocellular Carcinoma (HCC)A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
리드: BMS · 협력: 바이오엔테크
- 1/2상모집 중· Locally Advanced Breast CancerA Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
리드: 바이오엔테크
- 1/2상모집 중· Advanced Solid TumorsA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
협력: 바이오엔테크
- 1/2상모집 중단 (진행 중)· TuberculosisSafety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated Volunteers
리드: 바이오엔테크
- 1/2상모집 중단 (진행 중)· Advanced Solid TumorFirst-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors
협력: 바이오엔테크
- 1/2상모집 중· HER2-positive Advanced Solid TumorA Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
협력: 바이오엔테크
- 1/2상모집 중단 (진행 중)· Malignant Solid TumorGEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
협력: 바이오엔테크
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.